Evidence and regulatory context for peptide-based treatments connected to weight management.
Established / approved options
Semaglutide, tirzepatide, and liraglutide have FDA-approved products with weight-management indications. Product, eligibility, and indication matter.
Being researched
No research peptide is promoted as a recommended weight-management treatment.
How to use this page
Established options appear before experimental compounds. Goal relevance never overrides regulatory status or evidence quality.
Next step
Open the relevant treatment review for sources, risks, contraindications, and evidence gaps.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.